Delayed Graft Function  >>  cyclosporine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00154232: Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)

Completed
4
46
RoW
Enteric-Coated Mycophenolate Sodium (EC-MPS)
Novartis Pharmaceuticals
Renal Transplantation
03/05
 

Download Options